PACHTER, Jonathan, A.,RING, Jennifer, E.,WEAVER, David, T.,WANG, Yan
申请号：
EP16818676
公开号：
EP3313404A4
申请日:
2016.06.29
申请国别(地区):
EP
年份:
2019
代理人:
摘要：
This invention relates to methods comprising administering a FAK inhibitor and an immunotherapeutic agent such as anti-PD-1 or anti-PD-L1； that are useful in the treatment of abnormal cell growth, such as cancer, in mammals, especially humans.
